Does DEUCRAVACITINIB Cause Off label use? 101 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Off label use have been filed in association with DEUCRAVACITINIB (SOTYKTU). This represents 4.2% of all adverse event reports for DEUCRAVACITINIB.
101
Reports of Off label use with DEUCRAVACITINIB
4.2%
of all DEUCRAVACITINIB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Off label use From DEUCRAVACITINIB?
Of the 101 reports, 1 (1.0%) resulted in death, 6 (5.9%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEUCRAVACITINIB. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does DEUCRAVACITINIB Cause?
Drug ineffective (228)
Acne (225)
Pruritus (187)
Rash (175)
Erythema (124)
Psoriasis (122)
Adverse event (74)
Mouth ulceration (72)
Folliculitis (65)
Headache (65)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DEUCRAVACITINIB Alternatives Have Lower Off label use Risk?
DEUCRAVACITINIB vs DEUTETRABENAZINE
DEUCRAVACITINIB vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DEUCRAVACITINIB vs DEVICE
DEUCRAVACITINIB vs DEXAMETHASONE
DEUCRAVACITINIB vs DEXAMETHASONE\DEXAMETHASONE